Ajax-Loading

AbbVie Inc - Net Buyback Yield

AbbVie Inc's Fiscal Year is From January To December - All Figures are in Percent.

The item "Net-Buyback-Yield" stands at 0.4012 percent as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of AbbVie Inc's third quarter, the item "Net Buyback Yield" stands at 0.4012 Percent. This represents a decrease of -0.07 percentage points compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.154 percentage points compared to the value the year prior.
The 1 year change in percentage points is -0.154.
The 3 year change in percentage points is -0.5814.

The Serie's long term average value is 0.709 percent. It's latest available value, on 09/30/2025, is 0.307 percentage points lower, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0.
The Serie's change in percentage points from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -0.626.

Net Buyback Yield for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Net Buyback Yield905,699,262,464.00
LogoJohnson & Johnson - Net Buyback Yield486,508,953,600.00
LogoRoche Holding AG - Net Buyback Yield317,433,206,677.55
LogoAstraZeneca PLC - Net Buyback Yield280,205,508,085.11
LogoNovartis AG - Net Buyback Yield255,096,620,580.91